Associate Professor
Yoshihiko Hirohashi, M.D. Ph.D.
1. Establishment of cancer immunotherapy
Since acquired immune system recognize antigens, immunization of cancer patients using tumor-associated antigens (TAAs) will bring augmentation of anti-tumor immunity. On this point of view, ...
Associate Professor
Tomohide Tsukahara, M.D. Ph.D.
Research works in our team is focused on establishment of immunotherapy for bone and soft tissue sarcoma. We perform clinical peptide vaccination phase I trials, identify specific antigens of cancer stem-like cells/cancer-initiating cells, and develop artificial antibodies against HLA/peptide complex using antibody engineering technology...